Tanvex BioPharma, Inc. announced the appointment of Val Chen, VP of Finance - Tanvex BioPharma Inc., Director, Operation Management/chief internal auditor as Corporate governance officer. Effective date: July 1, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.65 TWD | +2.47% | +11.89% | -29.88% |
06-19 | Tanvex BioPharma, Inc. Appoints Val Chen as Corporate Governance Officer, Effective July 1, 2024 | CI |
06-19 | Tanvex BioPharma, Inc. Announces Change of Audit Committee Members | CI |
1st Jan change | Capi. | |
---|---|---|
-29.88% | 230M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma, Inc. Appoints Val Chen as Corporate Governance Officer, Effective July 1, 2024